When Abigail Burroughs was nineteen, she was diagnosed with cancer. She tried a variety of treatments, but none worked. After exhausting all of her government-approved options, Abigail had one last hope: Her doctors identified a promising treatment called Erbitux. The drug had not yet been approved for sale by the Food and Drug Administration (FDA); it …
Keep reading with a 7-day free trial
Subscribe to The Objective Standard to keep reading this post and get 7 days of free access to the full post archives.